| Urinary proteome profiling for stratifying patients with familial Parkinson’s disease S Virreira Winter, O Karayel, MT Strauss, S Padmanabhan, M Surface, ... EMBO molecular medicine 13 (3), e13257, 2021 | 92 | 2021 |
| Higher urine bis (monoacylglycerol) phosphate levels in LRRK2 G2019S mutation carriers: implications for therapeutic development RN Alcalay, F Hsieh, E Tengstrand, S Padmanabhan, M Baptista, ... Movement disorders 35 (1), 134-141, 2020 | 63 | 2020 |
| Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease O Karayel, SV Winter, S Padmanabhan, YI Kuras, DT Vu, I Tuncali, ... Cell Reports Medicine 3 (6), 2022 | 57 | 2022 |
| R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils Y Fan, RS Nirujogi, A Garrido, J Ruiz-Martínez, A Bergareche-Yarza, ... Acta Neuropathologica 142 (3), 475-494, 2021 | 48 | 2021 |
| Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding AF Kalogeropulou, E Purlyte, F Tonelli, SM Lange, M Wightman, ... Biochemical Journal 479 (17), 1759-1783, 2022 | 47 | 2022 |
| An assessment of LRRK2 serine 935 phosphorylation in human peripheral blood mononuclear cells in idiopathic Parkinson’s disease and G2019S LRRK2 cohorts S Padmanabhan, TA Lanz, D Gorman, M Wolfe, A Joyce, C Cabrera, ... Journal of Parkinson's Disease 10 (2), 623-629, 2020 | 33 | 2020 |
| Using global team science to identify genetic parkinson's disease worldwide. KC Vollstedt EJ, Kasten M, MGGPDS Group. Annals of Neurology 86 (2), 153-157, 2019 | 29 | 2019 |
| Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease M Surface, M Balwani, C Waters, A Haimovich, Z Gan‐Or, KS Marder, ... Movement Disorders 37 (2), 416-421, 2022 | 28 | 2022 |
| Constitutively active GPR6 is located in the intracellular compartments S Padmanabhan, AG Myers, BM Prasad FEBS letters 583 (1), 107-112, 2009 | 27 | 2009 |
| Evaluation of strategies for measuring lysosomal glucocerebrosidase activity D Ysselstein, TJ Young, M Nguyen, S Padmanabhan, WD Hirst, ... Movement Disorders 36 (12), 2719-2730, 2021 | 24 | 2021 |
| Activity‐dependent regulation of the dopamine transporter is mediated by Ca2+/calmodulin‐dependent protein kinase signaling S Padmanabhan, NA Lambert, BM Prasad European Journal of Neuroscience 28 (10), 2017-2027, 2008 | 24 | 2008 |
| Elevated in vitro kinase activity in peripheral blood mononuclear cells of Leucine‐rich repeat kinase 2 G2019S carriers: a novel enzyme‐linked immunosorbent assay–based method K Melachroinou, MS Kang, C Liong, S Narayan, N Levers, N Joshi, ... Movement Disorders 35 (11), 2095-2100, 2020 | 20 | 2020 |
| Embracing monogenic Parkinson's disease: the MJFF Global Genetic PD cohort EJ Vollstedt, S Schaake, K Lohmann, S Padmanabhan, A Brice, S Lesage, ... Movement Disorders 38 (2), 286-303, 2023 | 19 | 2023 |
| Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s disease M Hadisurya, L Li, K Kuwaranancharoen, X Wu, ZC Lee, RN Alcalay, ... Communications Medicine 3 (1), 64, 2023 | 18 | 2023 |
| The Michael J. fox Foundation for Parkinson’s research strategy to advance therapeutic development of PINK1 and Parkin S Padmanabhan, NK Polinski, LB Menalled, MAS Baptista, BK Fiske Biomolecules 9 (8), 296, 2019 | 18 | 2019 |
| The commercial genetic testing landscape for Parkinson's disease L Cook, J Schulze, J Verbrugge, JC Beck, KS Marder, ... Parkinsonism & related disorders 92, 107-111, 2021 | 17 | 2021 |
| Perspective on the current state of the LRRK2 field JM Taymans, M Fell, T Greenamyre, WD Hirst, A Mamais, ... npj Parkinson's Disease 9 (1), 104, 2023 | 14 | 2023 |
| A blood-based marker of mitochondrial DNA damage in Parkinson’s disease R Qi, E Sammler, CP Gonzalez-Hunt, I Barraza, N Pena, JP Rouanet, ... Science translational medicine 15 (711), eabo1557, 2023 | 11 | 2023 |
| Human peripheral blood neutrophil isolation for interrogating the Parkinson's associated LRRK2 kinase pathway by assessing Rab10 phosphorylation Y Fan, F Tonelli, S Padmanabhan, MAS Baptista, L Riley, D Smith, ... JoVE (Journal of Visualized Experiments), e58956, 2020 | 11 | 2020 |
| Differential Phospho‐Signatures in Blood Cells Identify LRRK2 G2019S Carriers in Parkinson's Disease A Garrido, E Santamaría, J Fernández‐Irigoyen, M Soto, C Simonet, ... Movement Disorders 37 (5), 1004-1015, 2022 | 10 | 2022 |
